Geisinger Medical Laboratories/Geisinger Proven Diagnostics Test Catalog

Test Name: Sunquest Test Code Epic Procedure Code Or ID CPT Code:  

ANTI-CARDIOLIPIN AB

ORDERING INFORMATION:
Sunquest Test Code:
CARDAB      Geisinger Epic Procedure Code: 86147         Geisinger Epic ID: 7283

SPECIMEN COLLECTION
Specimen type:
Serum (preferred) or sodium citrate plasma.
Preferred collection container:
Alternate Collection Container:
6 mL red-top (plain, non-serum separator) tube
2.7 mL blue-top (3.2% sodium citrate) tube
Specimen required:
0.5 mL serum; minimum 0.2 mL

SPECIMEN PROCESSING
Specimen processing instructions:
Allow to clot. Centrifuge and submit 0.5 mL serum. 
Transport temperature:
Refrigerated (preferred). Room temperature (stable 8 hours) and frozen specimens also acceptable.
Specimen stability:
Room temperature: 8 hours. 2-8°C: 48 hours. Frozen: 6 months.
Rejection criteria:
Specimen stability exceeded; specimen grossly hemolyzed.

TEST DETAILS
Reference interval:
Cardiolipin IgG (CARDG)< 15 GPL units = Negative.
Cardiolipin IgM (CARDM) < 12.5 MPL units = Negative.
Cardiolipin IgA (CARDA)< 12 APL units = Negative.
Additional information:
Sodium citrate plasma has been validated for use with this assay for those patients ordered for Anti-Lupus Coagulation panels (LUPACP or LUPACC) without an available serum sample.
CPT code(s):
86147 x 3
Note: The billing party has sole responsibility for CPT coding.  Any questions regarding coding should be directed to the payer being billed.  The CPT codes provided by GML are based on AMA guidelines and are for informational purposes only.
Test includes:
Cardiolipin Antibody IgG, Cardiolipin Antibody IgM, Cardiolipin Antibody IgA
Methodology:
Enzyme-Linked Immunosorbent Assay (ELISA)
Synonyms:
Anticardiolipin antibody panel
Antiphospholipid antibody panel
Antiphospholipid AB
ACA antibody panel, ACL antibody panel
Cardiolipin antibody
Clinical significance:
The presence of cardiolipin antibodies when used in conjunction with clinical findings and other laboratory tests can aid in assessing the risk of thromboembolic disease in patients with systemic lupus erythematosus (SLE) or primary anti-phospholipid syndrome (APS).
Doctoral Director(s:)
Stacy Kenyon, PhD, DABCC
Hoi-Ying Elsie Yu, PhD, DABCC    
Review Date: 10/24/2018

Performing Locations

Geisinger Medical Center

Performing laboratory: Immunology
Technical Lead: Kathy Hurst
Frequency: Tuesday, Friday 1st shift
Performed stat? No
Locations  |    Search  |    Site Map |   Contact Us
©2000-2019 Geisinger Health System.   All rights reserved.
*GMC - Geisinger Medical Center; GWV - Geisinger Wyoming Valley Medical Center; GSACH - Geisinger Shamokin Area Community Hospital; GBH - Geisinger Bloomsburg Hospital;
GCMC - Geisinger Community Medical Center (Scranton); GLH - Geisinger Lewistown Hospital; GHS - Geisinger Holy Spirit; GJSH - Geisinger Jersey Shore Hospital,
GSWB - Geisinger South Wilkes-Barre